Last $11.55 USD
Change Today +0.08 / 0.70%
Volume 26.7K
ICEL On Other Exchanges
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

cellular dynamics internatio (ICEL) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/26/13 - $24.11
52 Week Low
08/5/13 - $9.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

cellular dynamics internatio (ICEL) Related Businessweek News

No Related Businessweek News Found

cellular dynamics internatio (ICEL) Details

Cellular Dynamics International, Inc. develops and manufactures human cells in the United States of America, Europe, Japan, and internationally. The company’s proprietary iCell Operating System comprises human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs), and custom iPSCs and iCell products (MyCell products). It offers iCell Cardiomyocytes, which are purified human heart cells that beat in a dish and behave just like the heart cells found in the human body for in vitro drug discovery, toxicity testing, and chemical safety, as well as in vivo cellular therapeutics research and development, and stem cell banking; and iCell Neurons that are purified human neurons typical of the forebrain for pre-clinical drug discovery, neurotoxicity testing, and disease modeling for Alzheimer’s diseases, Parkinson’s diseases, Huntington’s diseases, and others. The company also provides iCell Endothelial cells, which are interior surface blood vessel cells for use in vascular biology research, such as angiogenesis, atherosclerosis, inflammation, and other life science research; and iCell Hepatocytes that are human liver cells for pre-clinical drug discovery, hepatotoxicity testing, disease modeling, and other life science research. In addition, it offers MyCell products for making iPSCs for stem cell banking, cell modeling of specific ethnic or disease populations, and genetic engineering for in vitro research; and media and reprogramming kits for making iPSCs for limited research use. The company serves biopharmaceutical companies, government research institutions, academic and nonprofit research institutions, contract research organizations, and stem cell banks. Cellular Dynamics International, Inc. was founded in 2004 and is headquartered in Madison, Wisconsin.

128 Employees
Last Reported Date: 03/11/14
Founded in 2004

cellular dynamics internatio (ICEL) Top Compensated Officers

Founder, Chairman of the Board and Chief Exec...
Total Annual Compensation: $475.0K
Founder, Vice Chairman and President
Total Annual Compensation: $475.0K
Chief Operating Officer and Vice President of...
Total Annual Compensation: $360.0K
Chief Commercial Officer and Vice President o...
Total Annual Compensation: $344.0K
Compensation as of Fiscal Year 2013.

cellular dynamics internatio (ICEL) Key Developments

Cellular Dynamics International, Inc. Announces Executive Changes

Cellular Dynamics International, Inc. announced the resignation of Mr. David S. Snyder as Executive Vice President and Chief Financial Officer of the Company, effective July 10, 2014. The company appointed Timothy D. Daley as Vice President and Interim Chief Financial Officer of the Company. As Interim CFO, Mr. Daley will become the company's principal financial officer and principal accounting officer, roles currently held by Mr. Snyder. In connection with Mr. Daley's appointment as Vice President and Interim CFO. Mr. Daley, has been a consultant to the Company since 2009. Since 2004, he has provided part-time and interim CFO/Controller and SEC reporting services to several organizations through his firm Timothy Daley CPA LLC.

Cellular Dynamics International, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2014

Cellular Dynamics International, Inc. reported unaudited earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported total revenues of $2,939,000 against $2,390,000 a year ago. Loss from operations was $7,813,000 against $5,679,000 a year ago. Net loss was $8,117,000 or $3.28 per basic and diluted share against $5,686,000 or $0.52 per basic and diluted share a year ago.

Cellular Dynamics International, Inc. Announces Launch of iCell(R) DopaNeurons

Cellular Dynamics International, Inc. announced the launch of iCell(R) DopaNeurons, the company's neural floor plate-derived midbrain dopaminergic neurons generated from human induced pluripotent stem cells (iPSCs). Dopaminergic neurons, specifically those located in the floor plate-derived midbrain, are implicated in neurological disorders such as Parkinson's disease and schizophrenia; thus iCell DopaNeurons provide a highly relevant in vitro model to investigate these types of pathologies. Midbrain dopaminergic neurons develop from an early developmental stage of the brain called the floor plate. Other commercially available iPSC-derived dopaminergic neurons do not follow this developmental path, but instead are derived from neural stem cells. Only midbrain dopaminergic neurons have been shown to be engraftable in animals (1), indicating the promise for the development of cell-based therapies. In addition to iCell DopaNeurons, CDI's MyCell(R) process can be applied to develop and manufacture cells from donors with dopaminergic neuron-based diseases.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICEL:US $11.55 USD +0.08

ICEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cellectis €11.95 EUR -0.04
General Electric Co $25.79 USD -0.15
Lonza Group AG SFr.101.00 CHF +1.10
Sigma-Aldrich Corp $102.98 USD +0.39
View Industry Companies

Industry Analysis


Industry Average

Valuation ICEL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.6x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLULAR DYNAMICS INTERNATIO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at